Humana reaffirms the 2025 adjusted EPS outlook of $16.25 versus the consensus of $16.35. For 2025, Humana expects its insurance segment’s benefit ratio guidance of approximately 90.1-90.5%.

It’s a stunning loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.

Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...

Humana delivered 60% adjusted EPS growth in the quarter and maintained its 2025 outlook. On an adjusted operating profit basis, medical insurance grew 75%, including a better medical loss ratio of ...

Humana Inc. forecast 2025 profit that fell short of Wall Street’s expectations, as the company said it will invest heavily to improve quality in its Medicare Advantage plans that have been hit ...

Discover insights from Humana's Q1 2025 earnings call: growth in Medicaid, strategic investments in CenterWell, and reaffirmed $16.25 EPS guidance.

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the ...

Humana ended the third quarter with 16.358 million in total medical membership, compared to 16.963 milli Humana Lifts 2024 Profit Outlook As Q3 Earnings Beat Street View On Medicare Strength Skip ...

Humana Inc. (NYSE:HUM) on Wednesday posted a first-quarter adjusted EPS of $11.58, up from $7.23 a year ago, beating the consensus of $10.07. Humana sales increased from $29.6 billion to $32.11 ...

Humana Does Not Alter 2025 Outlook Despite Sales Miss And Medicare Membership Decline. Humana Inc. (NYSE:HUM) on Wednesday posted a first-quarter adjusted EPS of $11.58, up from $7.23 a year ago, ...